Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
Go back to Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 212.55 +3.40 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.15 | 52 Week High | $333.65 | |||
| Open | $211.00 | 52 Week Low | $223.02 | |||
| Day High | $214.07 | P/E | 27.22 | |||
| Day Low | $210.01 | EPS | $7.81 | |||
| Volume | 693,992 | |||||
| (NASDAQ: STOK) | Delayed: 32.14 +0.01 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.13 | 52 Week High | $ | |||
| Open | $31.85 | 52 Week Low | $ | |||
| Day High | $32.67 | P/E | N/A | |||
| Day Low | $31.40 | EPS | $ | |||
| Volume | 574,555 | |||||
